272 related articles for article (PubMed ID: 10634604)
1. Reepithelialization of the human cornea is regulated by endogenous opioids.
Zagon IS; Sassani JW; McLaughlin PJ
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):73-81. PubMed ID: 10634604
[TBL] [Abstract][Full Text] [Related]
2. Opioid growth factor (OGF) inhibits anchorage-independent growth in human cancer cells.
Zagon IS; McLaughlin PJ
Int J Oncol; 2004 Jun; 24(6):1443-8. PubMed ID: 15138586
[TBL] [Abstract][Full Text] [Related]
3. Re-epithelialization of the rabbit cornea is regulated by opioid growth factor.
Zagon IS; Sassani JW; McLaughlin PJ
Brain Res; 1998 Aug; 803(1-2):61-8. PubMed ID: 9729280
[TBL] [Abstract][Full Text] [Related]
4. Nucleocytoplasmic distribution of opioid growth factor and its receptor in tongue epithelium.
Zagon IS; Ruth TB; McLaughlin PJ
Anat Rec A Discov Mol Cell Evol Biol; 2005 Jan; 282(1):24-37. PubMed ID: 15584033
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of the OGF-OGFr pathway by naltrexone accelerates fibroblast proliferation and wound healing.
Immonen JA; Zagon IS; McLaughlin PJ
Exp Biol Med (Maywood); 2014 Oct; 239(10):1300-9. PubMed ID: 25030485
[TBL] [Abstract][Full Text] [Related]
6. Opioid growth factor inhibits intimal hyperplasia in balloon-injured rat carotid artery.
Zagon IS; Essis FM; Verderame MF; Healy DA; Atnip RG; McLaughlin PJ
J Vasc Surg; 2003 Mar; 37(3):636-43. PubMed ID: 12618704
[TBL] [Abstract][Full Text] [Related]
7. Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.
McLaughlin PJ; Sassani JW; Klocek MS; Zagon IS
Brain Res Bull; 2010 Feb; 81(2-3):236-47. PubMed ID: 19683562
[TBL] [Abstract][Full Text] [Related]
8. Corneal wound healing is modulated by topical application of amniotic fluid in an ex vivo organ culture model.
Castro-Combs J; Noguera G; Cano M; Yew M; Gehlbach PL; Palmer J; Behrens A
Exp Eye Res; 2008 Jul; 87(1):56-63. PubMed ID: 18555991
[TBL] [Abstract][Full Text] [Related]
9. Homeostasis of ocular surface epithelium in the rat is regulated by opioid growth factor.
Zagon IS; Sassani JW; Kane ER; McLaughlin PJ
Brain Res; 1997 Jun; 759(1):92-102. PubMed ID: 9219867
[TBL] [Abstract][Full Text] [Related]
10. The opioid growth factor-opioid growth factor receptor axis: homeostatic regulator of cell proliferation and its implications for health and disease.
McLaughlin PJ; Zagon IS
Biochem Pharmacol; 2012 Sep; 84(6):746-55. PubMed ID: 22687282
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone, an opioid antagonist, facilitates reepithelialization of the cornea in diabetic rat.
Zagon IS; Jenkins JB; Sassani JW; Wylie JD; Ruth TB; Fry JL; Lang CM; McLaughlin PJ
Diabetes; 2002 Oct; 51(10):3055-62. PubMed ID: 12351447
[TBL] [Abstract][Full Text] [Related]
12. Opioids and differentiation in human cancer cells.
Zagon IS; McLaughlin PJ
Neuropeptides; 2005 Oct; 39(5):495-505. PubMed ID: 16169076
[TBL] [Abstract][Full Text] [Related]
13. The opioid growth factor, [Met5]-enkephalin, inhibits DNA synthesis during recornification of mouse tail skin.
Wilson RP; McLaughlin PJ; Lang CM; Zagon IS
Cell Prolif; 2000 Apr; 33(2):63-73. PubMed ID: 10845251
[TBL] [Abstract][Full Text] [Related]
14. The opioid growth factor, [Met5]-enkephalin, and the zeta opioid receptor are present in human and mouse skin and tonically act to inhibit DNA synthesis in the epidermis.
Zagon IS; Wu Y; McLaughlin PJ
J Invest Dermatol; 1996 Mar; 106(3):490-7. PubMed ID: 8648182
[TBL] [Abstract][Full Text] [Related]
15. The opioid growth factor (OGF) and low dose naltrexone (LDN) suppress human ovarian cancer progression in mice.
Donahue RN; McLaughlin PJ; Zagon IS
Gynecol Oncol; 2011 Aug; 122(2):382-8. PubMed ID: 21531450
[TBL] [Abstract][Full Text] [Related]
16. Adaptation of homeostatic ocular surface epithelium to chronic treatment with the opioid antagonist naltrexone.
Zagon IS; Sassani JW; McLaughlin PJ
Cornea; 2006 Aug; 25(7):821-9. PubMed ID: 17068460
[TBL] [Abstract][Full Text] [Related]
17. T lymphocyte proliferation is suppressed by the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: implication for the treatment of autoimmune diseases.
Zagon IS; Donahue RN; Bonneau RH; McLaughlin PJ
Immunobiology; 2011 May; 216(5):579-90. PubMed ID: 20965606
[TBL] [Abstract][Full Text] [Related]
18. Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model.
Carrier P; Deschambeault A; Talbot M; Giasson CJ; Auger FA; Guérin SL; Germain L
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1376-85. PubMed ID: 18385053
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the opioid growth factor receptor potentiates growth inhibition in human pancreatic cancer cells.
Zagon IS; Verderame MF; Hankins J; McLaughlin PJ
Int J Oncol; 2007 Apr; 30(4):775-83. PubMed ID: 17332915
[TBL] [Abstract][Full Text] [Related]
20. Re-epithelialization of the rat cornea is accelerated by blockade of opioid receptors.
Zagon IS; Sassani JW; McLaughlin PJ
Brain Res; 1998 Jul; 798(1-2):254-60. PubMed ID: 9666142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
